PASURTA®


Solution for injection in a pre-filled syringe
scheduling status
S4
registration number
54/7.3/0587, 54/7.3/0588
What PASURTA® contains
Erenumab 70 mg in 1.0 mL Erenumab 140 mg in 1.0 mL.
other ingredients
70 mg per mL pre-filled syringe • Sucrose: 73 mg/7.3 % (w/v); NF, Ph. Eur., JP • Glacial acetic acid: 1.5 mg/25 mM; USP, Ph. Eur., JP • Polysorbate 80: 0.10 mg/0.010 % (w/v); NF, Ph. Eur., JP • Water for injection • Sodium hydroxide to pH of 5.2; NF, Ph. Eur., JP 140 mg per mL pre-filled syringe • Sucrose: 65 mg/6.5 % (w/v); NF, Ph. Eur., JP • Glacial acetic acid: 2.0 mg/34 mM; USP, Ph. Eur., JP • Polysorbate 80: 0.10 mg/0.010 % (w/v); NF, Ph. Eur., JP • Water for injection • Sodium hydroxide to pH of 5.2; NF, Ph. Eur., JP.
Therapeutic classification
N02CD01.
© 2026 SAHPRA. ALL RIGHTS RESERVED